NEW DELHI: Serum Institute of India will produce up to an additional 100 million COVID-19 vaccine doses for India and low and middle-income countries in 2021.The company made this announcement taking forward the collaboration between SII, Gavi, Vaccine Alliance and Bill & Melinda Gates Foundation. The expansion follows August’s announcement of up to 100 million doses to be delivered by the collaboration and bringing the total now to be delivered to up to 200 million doses of vaccines
Serum Institute, the world’s largest vaccine producer, will manufacture an additional 100 million doses of Covid-19 vaccines, on the back of a further $150 million at-risk funding under its collaboration with Gavi (Global Alliance for Vaccines and Immunisation) and the Gates Foundation, reports Rupali Mukherjee. This takes the total to up to 200 million doses to be rolled out by 2021, under the partnership, of which “at least half or 100 million doses are committed to India”, sources told TOI.
The vaccine is expected to be priced around Rs 225-250 per dose for low- and middle-income countries (LMICs), including India.
The Gates Foundation is providing at-risk funding of a further $150 million to Gavi taking this collaboration to a total of $300 million to support this alliance.



Source link

By admin

Leave a Reply

Your email address will not be published. Required fields are marked *